U.S. sanctions Iranian airlines in aim to tighten economic squeeze as war spreads, oil rises
The Treasury Department on Tuesday sanctioned 27 Iranian airlines and a handful of other entities as part of its ongoing effort to isolate Iran's economy.
Finance & markets
Dow Analyst Moves: CSCO
On June 16, the Dow achieved a new milestone. The index advanced 0.64% or 328.64 points to close at a record high of 51,999.67. At intraday high, the blue-chip index touched an all-time high of 52,190.29. The index touc…
Daily Dividend Report: ABM,CLDT,FNWD,TSI,MXF
The ABM Board declared a cash dividend of $0.29 per common share, payable on November 2, 2026, to shareholders of record on October 1, 2026.
New Hampshire goes to the polls in primary for key open Senate seat
New Hampshire voters head to the polls Tuesday to nominate candidates for a key U.S. Senate race to replace the retiring Democratic Sen. Jeanne Shaheen. Both Democrats and Republicans are aiming to win the seat in their…
Tuesday's ETF Movers: COPX, PPH
In trading on Tuesday, the Global X Copper Miners ETF is outperforming other ETFs, up about 5.5% on the day. Components of that ETF showing particular strength include shares of Ivanhoe Electric, up about 12.5% and shar…
Chinese giants Xiaomi, Huawei race to get ahead of Apple’s rumored foldable iPhone
Huawei and Xiaomi this week rolled out their latest foldable phones as the Chinese tech giants look to steal a lead on rival Apple, which is rumored to launch its first foldable iPhone on Wednesday.
Tuesday Sector Leaders: Semiconductors, Metals & Mining Stocks
In trading on Tuesday, semiconductors shares were relative leaders, up on the day by about 5.9%. Leading the group were shares of Marvell Technology, up about 27.3% and shares of Magnachip Semiconductor up about 21.9% o…
'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat
American patients would ultimately bear the cost of President Donald Trump's threatened tariffs on generic drugs, the CEO of Swiss pharmaceutical company Sandoz told CNBC, warning that manufacturers could be forced to r…
Oil price approaches $100 a barrel after Saudi oil facilities attacked; UK mortgage rates highest since June – business live
Good morning, and welcome to our rolling coverage of business, the financial markets and the world economy.
Monday’s insider trading: No major buys or sells disclosed
On Feb. 10, an AI founder named Matt Shumer published a 5,000-word essay arguing that most of the world was sleepwalking into a crisis akin to coronavirus, but only tech people knew what was coming. The essay would be v…
Why the yen’s rise to a six-month high could go further
The yen strengthened to the 153 level against the dollar in Tokyo foreign exchange trading on the 8th, reaching its highest level against the greenback in roughly six months since February. Expectations for an accelerat…
Does Your Portfolio Need an Inflation Tax Break?
Inflation trends during the Trump and Biden administrations have reflected very different economic backdrops. In Trump’s first term, inflation remained relatively subdued and generally stayed near the Federal Reserve’s …
Trump’s approval rating is plummeting – as his fortune grows and grows | Arwa Mahdawi
If I had a dollar for every time Donald Trump said something inane, I would be a very rich woman. But even with an income that steady, I could never hope to be as flush as the president. A Forbes calculation from March …
Company News for Sep 8, 2026
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
I lost my savings after falling for a job interview scam
Job seekers are warned to be on the lookout, as scammers are trying to trick people on job listing websites into downloading fake interview tools.
United Natural Foods earnings beat by $0.08, revenue fell short of estimates
United Natural Foods (NYSE:UNFI - Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.69 EPS for the quarter, topping analysts' consensus estimates of $0.62 by $0.07, FiscalAI repor…
Looking Beyond Your Home Market? Here’s How AI Can Help Find Global Opportunities
This article was featured in the One Story to Read Today newsletter. Sign up for it here.
Canada's retaliatory tariffs worth $27.6 billion take effect as trade rift with U.S. deepens
Canada's retaliatory tariffs on a swathe of U.S. goods took effect on Tuesday after trade talks collapsed last month, as relations between Washington and Ottawa continue to sour.
Chip stock investors beware — these charts could warn of further weakness ahead
U.S. stock investors have reason to pay attention to the currency market for signs of how money may be flowing in and out of chip stocks.
Assets: Separated but Not Divorced—The Underestimated Risks
Some separated couples put off getting a divorce for years, whether out of convenience, shame, or self-interest. While there are some advantages, this also carries financial and legal disadvantages.
What You Should Eat to Protect the Good Bacteria in Your Mouth
Everyone knows that sugary foods can cause cavities by feeding the harmful bacteria in our mouths. But it turns out that keeping them in check depends as much on what you eat as on what you don’t eat. And from fruits to…
Pharma major Novartis falls 9% after three drug trial setbacks
Novartis shares tanked on Tuesday after the pharmaceutical giant said its del-desiran drug for muscle-wasting disorder failed in a late-stage trial.
Global markets keep shrugging off shocks. Here's what could break that streak, according to HSBC
Global markets have shrugged off a barrage of shocks in recent years, but HSBC sees several developments that could eventually end that streak.
Cholesterol drug setback casts doubt over multibillion-dollar race
Novartis' failure in a closely watched cardiovascular trial has raised questions about one of the pharmaceutical industry's biggest drug races and rival treatments from U.S. heavyweights Amgen and Eli Lilly.